NCT04673682View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

May 17, 2022

Study Completion Date

June 7, 2022

Conditions
Hypogonadism
Interventions
DRUG

D309

D309(Testosterone) 1 vial, Once, IM injection

DRUG

CKD-845

CKD-845(Testosterone) 1 vial, Once, IM injection

Trial Locations (1)

54907

Jeonbuk University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY